Unveiling Common Transcriptomic Features between Melanoma Brain Metastases and Neurodegenerative Diseases.
Autores de CIPF
Participantes ajenos a CIPF
- Soler-Sáez I
- Karz A
- Gómez-Cabañes B
- López-Cerdán A
- Prutisto-Chang K
- Eskow NM
- Izar B
- Redmer T
- Kumar S
- Davies MA
- Hernando E
Grupos de Investigación
Abstract
Melanoma represents a critical clinical challenge owing to its unfavorable outcomes. This type of skin cancer exhibits unique adaptability to the brain microenvironment, but its underlying molecular mechanisms are poorly understood. Recent findings have suggested that melanoma brain metastases may share biological processes similar to those found in various neurodegenerative diseases. To further characterize melanoma brain metastasis development, we explore the relationship between the transcriptional profiles of melanoma brain metastases and the neurodegenerative diseases Alzheimer's disease, Parkinson's disease, and multiple sclerosis. We take an in silico approach to unveil a neurodegenerative signature of melanoma brain metastases compared with those of melanoma nonbrain metastasis (53 dysregulated genes were enriched in 11 functional terms, such as associated terms to the extracellular matrix and development) and with those of nontumor-bearing brain controls (195 dysregulated genes, mostly involved in development and cell differentiation, chromatin remodeling and nucleosome organization, and translation). Two genes, ITGA10 and DNAJC6, emerged as key potential markers being dysregulated in both scenarios. Finally, we developed an open-source, user-friendly web tool (https://bioinfo.cipf.es/metafun-mbm/) that allows interactive exploration of the complete results.
Datos de la publicación
- ISSN/ISSNe:
- 0022-202X, 1523-1747
- Tipo:
- Article
- Páginas:
- -
- PubMed:
- 39326662
JOURNAL OF INVESTIGATIVE DERMATOLOGY ELSEVIER SCIENCE INC
Documentos
- No hay documentos
Filiaciones
Keywords
- Alzheimer’s disease, Melanoma brain metastasis, Multiple sclerosis, Neurobiology, Parkinson’s disease
Proyectos asociados
PID10470. No se ingresará dinero en el CIPF. La ayuda consiste en un estudio genómico (long & read-sequencing) para 25 muestras.
Investigador Principal: CARMEN ESPINÓS ARMERO
EASI- Genomics . 2020
Nanoplataforma Polipeptídica Multimodal de Precisión para el Tratamiento y Monitorización de Tumores Metastásicos. Colab I-36, I-12, I-63, servicio citómica, uji y gva (Esther Roselló)
Investigador Principal: MARIA JESUS VICENT DOCON
CONSELLERIA DE EDUCACION . 2022
ESTUDIO DE LAS DIFERENCIAS DE SEXO EN ENFERMEDADES NEURODEGENERATIVAS CON ABORDAJES
Investigador Principal: FRANCISCO GARCÍA GARCÍA
MINISTERIO DE CIENCIA, INNOVACION Y UNIVERSIDADES . 2022
TECNICO INFRAESTRUCTURAS
Investigador Principal: FRANCISCO GARCÍA GARCÍA
MINISTERIO DE CIENCIA, INNOVACION Y UNIVERSIDADES . 2024
Ayuda Movilidad FPU20/03544
Investigador Principal: FRANCISCO GARCÍA GARCÍA
MINISTERIO EDUCACIÓN, CULT. Y DEPO. . 2024
Metabolic strategies to stimulate myelin repair and prevent
MINISTERIO DE SANIDAD Y POL. SOC. E IGUAL.- PNSD . 2024
Impacto de la diferencia de sexo en las enfermedades de Park
Investigador Principal: FRANCISCO GARCÍA GARCÍA
GENERALITAT VALENCIANA . 2024
EMBO Scientific Exchange Grant - Irene Soler
Investigador Principal: FRANCISCO GARCÍA GARCÍA
EMBO . 2024